Why the study?
Does the evolution of a simplified visual quantitative score (SQS) of late gadolinium enhancement (LGE) on cardiac MRI predict outcomes in patients with acute myocarditis?
Does the evolution of a simplified visual quantitative score (SQS) of late gadolinium enhancement (LGE) on cardiac MRI predict outcomes in patients with acute myocarditis?
A simplified visual quantitative score of late gadolinium enhancement on cardiac MRI between baseline and 3 months can help identify acute myocarditis patients at higher risk for adverse clinical outcomes at 1 year.
SQS evolution may aid risk stratification in acute myocarditis; leaves open whether serial CMR should guide care pending prospective validation.
PURPOSE: To determine the value of cardiac MRI for the monitoring and the prognosis of patients with acute myocarditis. Cardiac MRI plays an increasingly important role in the diagnosis of acute myocarditis. However, it is less established as a prognostic tool, which requires specific postprocessing of images. MATERIALS AND METHODS: In a prospective pilot study, we assessed the prognostic value of the evolution in a simplified visual quantitative score (SQS) of late gadolinium enhancement (LGE) between initial hospitalization and 3 months later. The prognostic value was assessed at 1 year using a combination of death, heart transplant, and confirmed recurrence as main outcome. RESULTS: Twenty-eight patients were included in this study. A significant correlation was found between LGE measured by SQS and planimetry (r = 0.95, P < 0.001). Intraobserver and interobserver reproducibilities were good for SQS (ICC = 0.95 [95% CI: 0.86 to 0.98], and 0.94 [95% CI: 0.84 to 0.98], respectively). At initial hospitalization, patient characteristics between the two groups were similar. Patients with stable or increased SQS suffered more frequently from clinical outcome events than patients with a decrease in SQS (P = 0.02). CONCLUSION: Monitoring of the evolution of LGE using a simple visual score is of interest to identify patients at risk of pejorative prognosis after acute myocarditis.
No takes yet. Share an insight, caveat, or question.
Barone‐Rochette et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: